| Teva invests $3.5M in Rexahn - Bizjournals.com |
|
|
Bizjournals.comRexahn (OTC BB: RXHN) says the proceeds will help it continue to develop its three leading compounds, drugs it is developing to treat renal cancer, ...Rexahn Pharmaceuticals and Teva Pharmaceutical Industries Agree to ... Business Wire (press release)Pharmaceuticals, - Rexahn Pharmaceuticals and Teva Pharmaceutical ... read more |